Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dissecting Aneurysm of the Thoracic Aorta”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06930222
What this trial is testing

The Investigation of Predicting Mortality and Morbidity in Patients Admitted to Intensive Care Unit With Thoracic Trauma Using Selected Biomarkers and Parameters

Who this might be right for
Thorax Traumas
Suleyman Demirel University 50
Early research (Phase 1)Study completedNCT00965731
What this trial is testing

Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Pfizer 27
Not applicableLooking for participantsNCT04410302
What this trial is testing

Patient-Derived Xenografts to Reduce Cancer Health Disparities

Who this might be right for
Bladder CarcinomaGastric CarcinomaLiver and Intrahepatic Bile Duct Carcinoma+2 more
University of California, Davis 500
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Not applicableNot Yet RecruitingNCT07539701
What this trial is testing

An Initial Experience With the Disposable Celsio Cryocatheter System for Diagnostic and Interventional Bronchoscopy

Who this might be right for
Lung Cancer (Diagnosis)Interstitial Lung Disease (ILD)
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval 30
Early research (Phase 1)UnknownNCT04942301
What this trial is testing

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

Who this might be right for
Advanced or Metastatic NSCLC
Jiangsu Simcere Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT03510611
What this trial is testing

Investigate the Food Effect on the Pharmacokinetics of Ensartinib Capsules in Chinese Healthy Volunteers.

Who this might be right for
Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 24
Large-scale testing (Phase 3)Ended earlyNCT00858364
What this trial is testing

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Who this might be right for
Non-Small Cell Lung CancerAnemiaCancer+1 more
Amgen 2,549
Not applicableUnknownNCT02239432
What this trial is testing

Telomere Biology in Early Adenocarcinoma of the Lung

Who this might be right for
Adenocarcinoma of the LungAdenocarcinoma, Bronchiolo-Alveolar
Meir Medical Center 100
Testing effectiveness (Phase 2)WithdrawnNCT00385398
What this trial is testing

QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC

Who this might be right for
Lung CancerMetastatic Cancer
University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)UnknownNCT01019798
What this trial is testing

Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Taipei Medical University Hospital 16
Testing effectiveness (Phase 2)Ended earlyNCT02556593
What this trial is testing

IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases

Who this might be right for
Non-Small Cell Lung Carcinoma
Sun Yat-sen University 12
Testing effectiveness (Phase 2)Study completedNCT00661193
What this trial is testing

S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 59
Not applicableStudy completedNCT00111176
What this trial is testing

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

Who this might be right for
Thoracic Aortic Aneurysm
Cook Group Incorporated 260
Testing effectiveness (Phase 2)WithdrawnNCT02466568
What this trial is testing

Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung

Who this might be right for
Lung CancerAdenocarcinoma of the Lung
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Study completedNCT00580320
What this trial is testing

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

Who this might be right for
MelanomaSoft Tissue SarcomaParathyroid Carcinoma+2 more
Virginia Commonwealth University 17
Post-approval studies (Phase 4)Looking for participantsNCT07632820
What this trial is testing

Erector Spinae Plane Block Versus Trigger Point Injection for Chronic Thoracic Myofascial Pain

Who this might be right for
Back Pain
Mayo Clinic 76
Not applicableStudy completedNCT03144479
What this trial is testing

New Technique to Assess Correct Positioning of the Right-sided Double Lumen Tube

Who this might be right for
AnesthesiaThoracic Diseases
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 10
Large-scale testing (Phase 3)Looking for participantsNCT06607796
What this trial is testing

Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy

Who this might be right for
Lung Cancer
Zhou Chengzhi 180
Testing effectiveness (Phase 2)Looking for participantsNCT05379985
What this trial is testing

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Revolution Medicines, Inc. 754
Next Page